{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:17:11Z","timestamp":1793222231235,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although patients suffering from atrial fibrillation have increased worldwide, detailed information about factors associated with bleeding during direct oral anticoagulant therapy remains insufficient. We studied 1086 patients for whom direct oral anticoagulants were initiated for non-valvular atrial fibrillation between April 2011 and June 2017. Endpoints were clinically relevant bleeding or major adverse cardiac and cerebrovascular events until the end of December 2018. Incidences of bleeding and thrombosis were 4.5 per 100 person-years and 4.7 per 100 person-years, respectively. Most bleeding events represented gastrointestinal bleeding. Multivariate analysis revealed initiation of anticoagulants at\u2009\u2265\u200985\u00a0years old as significantly associated with bleeding, particularly gastrointestinal bleeding, but not major cardiac and cerebrovascular events. Other significant factors included chronic kidney disease, low-dose aspirin and nonsteroidal anti-inflammatory drugs. For gastrointestinal bleeding alone, histories of gastrointestinal bleeding and malignancy also showed positive correlations, in addition to the above-mentioned factors. Clinicians should pay greater attention to the risk of gastrointestinal bleeding when considering prescription of anticoagulants to patients\u2009\u2265\u200985\u00a0years old with atrial fibrillation.<\/jats:p>","DOI":"10.1038\/s41598-020-77174-z","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T11:03:13Z","timestamp":1605783793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical factors associated with safety and efficacy in patients receiving direct oral anticoagulants for non-valvular atrial fibrillation"],"prefix":"10.1038","volume":"10","author":[{"given":"Hiroshi","family":"Yamato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Osumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yanagisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kodashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinari","family":"Asaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kozuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatsugu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"77174_CR1","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jacc.2009.07.019","volume":"54","author":"E Nikolsky","year":"2009","unstructured":"Nikolsky, E., Stone, G. W. & Kirtane, A. J. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J. Am. Col. Cardiol. 54, 1293\u20131302 (2009).","journal-title":"J. Am. Col. Cardiol."},{"key":"77174_CR2","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","volume":"112","author":"S Colilla","year":"2013","unstructured":"Colilla, S. et al. Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am. J. Cardiol. 112, 1142\u20131147 (2013).","journal-title":"Am. J. Cardiol."},{"key":"77174_CR3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0140-6736(16)31257-0","volume":"388","author":"B Freedman","year":"2016","unstructured":"Freedman, B., Potpara, T. S. & Lip, G. Y. Stroke prevention in atrial fibrillation. Lancet 388, 806\u2013817 (2016).","journal-title":"Lancet"},{"key":"77174_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3949\/ccjm.84a.16016","volume":"84","author":"T Hagerty","year":"2017","unstructured":"Hagerty, T. & Rich, M. W. Fall risk and anticoagulation for atrial fibrillation in the elderly: a delicate balance. Cleve. Clin. J. Med. 84, 35\u201340 (2017).","journal-title":"Cleve. Clin. J. Med."},{"key":"77174_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/CIA.S111216","volume":"23","author":"JM Foody","year":"2017","unstructured":"Foody, J. M. Reducing the risk of stroke in elderly patients with non-valvular atrial fibrillation: a practical guide for clinicians. Clin. Interv. Aging 23, 175\u2013187 (2017).","journal-title":"Clin. Interv. Aging"},{"key":"77174_CR6","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","volume":"361","author":"SJ Connolly","year":"2009","unstructured":"Connolly, S. J. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 361, 1139\u20131151 (2009).","journal-title":"N. Engl. J. Med."},{"key":"77174_CR7","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","volume":"365","author":"MR Patel","year":"2011","unstructured":"Patel, M. R. et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 365, 883\u2013891 (2011).","journal-title":"N. Engl. J. Med."},{"key":"77174_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","volume":"365","author":"CB Granger","year":"2011","unstructured":"Granger, C. B. et al. Apixaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 365, 981\u2013992 (2011).","journal-title":"N. Engl. J. Med."},{"key":"77174_CR9","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","volume":"369","author":"RP Giugliano","year":"2013","unstructured":"Giugliano, R. P. et al. Once-daily edoxaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 369, 2093\u20132104 (2013).","journal-title":"N. Engl. J. Med."},{"key":"77174_CR10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.amjcard.2017.05.055","volume":"120","author":"JM Ashburner","year":"2017","unstructured":"Ashburner, J. M., Singer, D. E., Lubitz, S. A., Borowsky, L. H. & Atlas, S. J. Changes in use of anticoagulation in patients with atrial fibrillation within a primary care network associated with the introduction of direct oral anticoagulants. Am. J. Cardiol. 120, 786\u2013791 (2017).","journal-title":"Am. J. Cardiol."},{"issue":"574","key":"77174_CR11","first-page":"e13","volume":"131","author":"GYH Lip","year":"2018","unstructured":"Lip, G. Y. H., Skj\u00f8th, F., Nielsen, P. B., Kj\u00e6ldgaard, J. N. & Larsen, T. B. The HAS-BLED, ATRIA, and ORBIT bleeding scores in atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants. Am. J. Med. 131(574), e13-574.e27 (2018).","journal-title":"Am. J. Med."},{"key":"77174_CR12","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00380-019-01425-x","volume":"34","author":"I Sakurai","year":"2019","unstructured":"Sakurai, I. et al. Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND study sub-analysis. Heart Vessels 34, 1839\u20131851 (2019).","journal-title":"Heart Vessels"},{"key":"77174_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters, R. et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138, 1093\u20131100 (2010).","journal-title":"Chest"},{"key":"77174_CR14","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1253\/circj.CJ-14-0144","volume":"78","author":"K Okumura","year":"2014","unstructured":"Okumura, K. et al. Validation of CHA2DS2-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry. Circ. J. 78, 1593\u20131599 (2014).","journal-title":"Circ. J."},{"key":"77174_CR15","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof, P. et al. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 37, 2893\u20132962 (2016).","journal-title":"Eur. Heart J."},{"key":"77174_CR16","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1378\/chest.15-1095","volume":"149","author":"Y Yamashita","year":"2016","unstructured":"Yamashita, Y. et al. Clinical characteristics and outcomes in extreme elderly (Age >=85 years Japanese patients with atrial fibrillation: the Fushimi AF registry. Chest 149, 401\u2013412 (2016).","journal-title":"Chest"},{"key":"77174_CR17","doi-asserted-by":"publisher","first-page":"e005657","DOI":"10.1161\/JAHA.117.005657","volume":"6","author":"G Patti","year":"2017","unstructured":"Patti, G. et al. Thromboembolic risk, bleeding outcomes and effect of different antithrombotic strategies in very elderly patients with atrial fibrillation: a sub-analysis from PREFER in AF. J. Am. Heart Assoc. 6, e005657 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"77174_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/clc.23293","volume":"43","author":"YG Kim","year":"2020","unstructured":"Kim, Y. G. et al. Impact of age on thromboembolic events in patients with non-valvular atrial fibrillation. Clin. Cardiol. 43, 78\u201385 (2020).","journal-title":"Clin. Cardiol."},{"key":"77174_CR19","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1161\/STROKEAHA.108.526988","volume":"40","author":"C van Walraven","year":"2009","unstructured":"van Walraven, C. et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators. Stroke 40, 1410\u20131416 (2009).","journal-title":"Stroke"},{"key":"77174_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"TJ Craig","year":"2019","unstructured":"Craig, T. J. et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/ American Heart Association Task Force on clinical practice guidelines and the heart rhythm society. J. Am. Coll. Cardiol. 74, 104\u2013132 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77174_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1001\/jamainternmed.2014.5398","volume":"175","author":"I Hernandez","year":"2015","unstructured":"Hernandez, I., Baik, S. H., Pi\u00f1era, A. & Zhang, Y. Risk of bleeding with dabigatran in atrial fibrillation. JAMA Intern. Med. 175, 18\u201324 (2015).","journal-title":"JAMA Intern. Med."},{"key":"77174_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.hrthm.2018.08.016","volume":"16","author":"H Alnsasra","year":"2019","unstructured":"Alnsasra, H. et al. Net clinical benefit of anticoagulant treatments in elderly patients with nonvalvular atrial fibrillation: experience from the real world. Heart Rhythm 16, 31\u201337 (2019).","journal-title":"Heart Rhythm"},{"key":"77174_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40268-019-0275-y","volume":"19","author":"J Lobraico-Fernandez","year":"2019","unstructured":"Lobraico-Fernandez, J., Baksh, S. & Nemec, E. Elderly bleeding risk of direct oral anticoagulants in nonvalvular atrial fibrillation: a systematic review and meta-analysis of cohort studies. Drugs R. D. 19, 235\u2013245 (2019).","journal-title":"Drugs R. D."},{"key":"77174_CR24","doi-asserted-by":"publisher","first-page":"e0216831","DOI":"10.1371\/journal.pone.0216831","volume":"14","author":"D Poli","year":"2019","unstructured":"Poli, D. et al. Oral anticoagulation in very elderly patients with atrial fibrillation: results from the prospective multicenter START2-REGISTER study. PLoS ONE 14, e0216831 (2019).","journal-title":"PLoS ONE"},{"key":"77174_CR25","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.cgh.2017.04.031","volume":"15","author":"CS Miller","year":"2017","unstructured":"Miller, C. S., Dorreen, A., Martel, M., Huynh, T. & Barkun, A. N. Risk of gastrointestinal bleeding in patients taking non-vitamin K antagonist oral anticoagulants: a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 15, 1674-1683.e3 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"77174_CR26","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1053\/j.gastro.2016.12.018","volume":"152","author":"NS Abraham","year":"2017","unstructured":"Abraham, N. S., Noseworthy, P. A., Yao, X., Sangaralingham, L. R. & Shah, N. D. Gastrointestinal safety of direct oral anticoagulants: a large population-based study. Gastroenterology 152, 1014-1022.e1 (2017).","journal-title":"Gastroenterology"},{"key":"77174_CR27","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.cgh.2018.05.005","volume":"16","author":"N Sengupta","year":"2018","unstructured":"Sengupta, N., Marshall, A. L., Jones, B. A., Ham, S. & Tapper, E. B. Rebleeding vs thromboembolism after hospitalization for gastrointestinal bleeding in patients on direct oral anticoagulants. Clin. Gastroenterol. Hepatol. 16, 1893-1900.e2 (2018).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"77174_CR28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1053\/j.gastro.2015.05.002","volume":"149","author":"EW Chan","year":"2015","unstructured":"Chan, E. W. et al. Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study. Gastroenterology 149, 586-595.e3 (2015).","journal-title":"Gastroenterology"},{"key":"77174_CR29","doi-asserted-by":"publisher","first-page":"7123607","DOI":"10.1155\/2018\/7123607","volume":"2018","author":"K Maruyama","year":"2018","unstructured":"Maruyama, K. et al. Difference between the upper and the lower gastrointestinal bleeding in patients taking nonvitamin K oral anticoagulants. Biomed. Res. Int. 2018, 7123607 (2018).","journal-title":"Biomed. Res. Int."},{"key":"77174_CR30","doi-asserted-by":"publisher","first-page":"e0160046","DOI":"10.1371\/journal.pone.0160046","volume":"11","author":"LA Garc\u00eda Rodr\u00edguez","year":"2016","unstructured":"Garc\u00eda Rodr\u00edguez, L. A., Mart\u00edn-P\u00e9rez, M., Hennekens, C. H., Rothwell, P. M. & Lanas, A. Bleeding risk with long-term low-dose Aspirin: a systematic review of observational studies. PLoS ONE 11, e0160046 (2016).","journal-title":"PLoS ONE"},{"key":"77174_CR31","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1586\/14779072.2015.1071665","volume":"13","author":"GY Lip","year":"2015","unstructured":"Lip, G. Y. Nonsteroidal anti-inflammatory drugs and bleeding risk in anticoagulated patients with atrial fibrillation. Expert Rev. Cardiovasc. Ther. 13, 963\u2013965 (2015).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"77174_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/ndt\/gfy031","volume":"34","author":"J Feldberg","year":"2019","unstructured":"Feldberg, J. et al. A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation. Nephrol. Dial. Transpl. 34, 265\u2013277 (2019).","journal-title":"Nephrol. Dial. Transpl."},{"key":"77174_CR33","first-page":"CD011373","volume":"11","author":"M Kimachi","year":"2017","unstructured":"Kimachi, M. et al. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Cochrane Database Syst. Rev. 11, CD011373 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"77174_CR34","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/ejh.13208","volume":"102","author":"J Weber","year":"2019","unstructured":"Weber, J., Olyaei, A. & Shatzel, J. The efficacy and safety of direct oral anticoagulants in patients with chronic renal insufficiency: a review of the literature. Eur. J. Haematol. 102, 312\u2013318 (2019).","journal-title":"Eur. J. Haematol."},{"key":"77174_CR35","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/pace.13811","volume":"42","author":"HS Bhatia","year":"2019","unstructured":"Bhatia, H. S., Bailey, J., Unlu, O., Hoffman, K. & Kim, R. J. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease. Pacing Clin. Electrophysiol. 42, 1463\u20131470 (2019).","journal-title":"Pacing Clin. Electrophysiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77174-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77174-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:50:00Z","timestamp":1670370600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77174-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["77174"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-77174-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"8 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20144"}}